Thérapie par cellules souches pour la maladie de Parkinson en Thaïlande — recevez 3 correspondances personnalisées de cliniques

Primary risks for stem cell therapy in Thailand include biological complications like tumour formation and immune rejection. There are also hazards during administration. While clinics use mesenchymal stem cells (MSCs) to reduce rejection, the treatment is still experimental. This means labs must follow strict standards and screen donors to prevent contamination.

• Cellular risks: Pluripotent cells carry tumorigenicity risks where cells may grow uncontrollably or form tumours.
• Administration hazards: Direct neurosurgical delivery involves risks of cerebral haemorrhage, tissue damage, or infections.
• Intrathecal risks: Injecting cells into the spinal canal carries risks of infection or neurological disruptions.
• Regulatory gaps: Compliance with Thai FDA standards for cell manipulation varies across private medical centres.

Bookimed Expert Insight: Patients often focus on cell counts, but the administration method is a major safety factor. Specialised centres like EDNA Wellness employ neurosurgeons like Dr Pongwat Polpong. He has performed 2,000+ procedures and oversees neurological delivery. This specialist supervision is safer than clinics where GPs handle complex central nervous system injections.

Patient Consensus: Many families in Thailand advise checking sterility testing and written details on cell sources. They suggest coordinating with a local neurologist so ongoing care is not disrupted by experimental treatments.

Stem cell therapy is not a proven medical cure for Parkinson’s disease in Thailand. Leading clinics in Bangkok classify these regenerative procedures as experimental management tools rather than a definitive cure. Treatments use mesenchymal stem cells (MSCs) to target inflammation and protect existing neurons to help manage symptoms.

• Primary objective: Treatment aims to reduce brain inflammation and slow down physical disease progression.
• Symptom management: Patients typically focus on improving tremors, rigidity, posture, mobility, and sleep quality.
• Delivery methods: Specialists administer cells through intravenous (IV) drips or intrathecal (IT) spinal injections.
• Clinical oversight: Neurosurgeons like Dr Pongwat Polpong at EDNA Wellness supervise these neurological programmes.

Bookimed Expert Insight: Data shows a significant range in cell dosages. High-dose protocols reach 160 million MSCs. These intensive packages, offered by providers like Vega Clinic, often include 6-day hospital stays. This suggests that clinics offering higher cell counts also include longer observation periods for patient safety.

Patient Consensus: Patients find that stem cell therapy in Thailand provides a supportive secondary option alongside conventional medications. Many experience modest improvements in daily mobility but treat marketing claims of a cure with caution.

Stem cell therapy in Thailand for Parkinson's disease focuses on reducing neuro-inflammation. It also aims to protect existing neurons. While commercial clinics report success rates of 70–80%, these reflect symptom management. These treatments are not a cure. Real benefits include improved motor control, fewer tremors, and better daily function.

• Cell administration: Clinics use intravenous (IV) or intrathecal (IT) injections of mesenchymal stem cells (MSCs).
• Doserange: Protocols typically use 40 million to 160 million MSCs per treatment cycle.
• Specific benefits: Patients often see less muscle rigidity and fewer freezing episodes.
• Neurological supervision: Centres like EDNA Wellness involve neurosurgeons such as Dr Pongwat Polpong.

Bookimed Expert Insight: Bookimed data shows clinics deliver cells to the brain in different ways. While standard IV infusions are common, others like Vega Clinic offer combined delivery. This uses both IV and intrathecal (spinal) methods. This dual approach aims to bypass the blood-brain barrier more effectively.

Patient Consensus: Expect modest and temporary benefits rather than a full disease reversal. Patients suggest confirming cell counts before travelling to Thailand. They also recommend requesting written follow-up plans.

Clinics in Thailand administer stem cells to Parkinson’s patients primarily through intravenous (IV) infusion and intrathecal (IT) injection. These procedures often use mesenchymal stem cells (MSCs) derived from the umbilical cord. Specialists typically combine both delivery methods over 3 to 6 days. This targets systemic inflammation and bypasses the blood-brain barrier.

• Intravenous infusion: Delivers millions of MSCs into the bloodstream via a controlled drip.
• Intrathecal injection: Injects cells directly into the spinal canal via a lumbar puncture.
• Combined protocol: Providers often recommend both IV and IT routes for maximum cellular coverage.
• Cell preparation: Laboratories prepare precise dosages, ranging from 40 million to 160 million MSCs.

Bookimed Expert Insight: Basic packages start from $25,800. Premium options at clinics like Vega Clinic often include 160 million stem cells. This is a significantly higher dose than standard global protocols. Data shows that lead specialists there, such as Dr Chollawat Thongthaisin, hold American Board of Regenerative Medicine certification. This bridges the gap between Thai clinical practice and Western medical standards.

Patient Consensus: Patients travelling to Thailand value the high-volume experience of Bangkok clinics. They also appreciate inclusive packages that handle local transport. Many find that having a neurologist and neurosurgeon supervise the procedure provides extra clinical reassurance.

Thai clinics primarily use Mesenchymal Stem Cells (MSCs) for Parkinson's care. These focus on reducing neuroinflammation and protecting dopamine-producing neurons. Facilities in Bangkok and Phuket specialise in umbilical cord-derived cells. Autologous options using a patient's own fat or bone marrow tissues remain available.

• Umbilical cord-MSCs: These allogeneic cells are highly potent and carry low immune rejection risks.
• Adipose-derived cells: Surgeons harvest these autologous cells from the patient's own fat tissue.
• Bone marrow-derived: These are extracted from the hip and are a long-studied source.
• Diverse administration: Specialists deliver cells via intravenous (IV) infusion or intrathecal (spinal) injection.
• Specialist expertise: Dr Pongwat Polpong at EDNA Wellness has performed 2,000+ neurosurgical procedures.

Bookimed Expert Insight: Many clinics offer general IV infusions. However, Bookimed data shows high-tier packages at Vega Clinic often combine IV and intrathecal delivery. This dual approach aims to bypass the blood-brain barrier. Dosing ranges from 40 million to 160 million cells, which significantly impacts the price.

Patient Consensus: Patients in Thailand recommend requesting written confirmation of the cell source. They also suggest checking processing certifications, such as AABB. Most find that all-inclusive packages simplify logistics by bundling airport transfers and hospital stays.

Specialised centres in Thailand perform stem cell therapy for Parkinson's disease. These include Vega Clinic, EDNA Wellness, and ID Clinic Bangkok. These clinics use mesenchymal stem cells (MSCs) through intravenous infusions or intrathecal injections. Specialists like Dr Pongwat Polpong and Dr Chollawat Thongthaisin oversee neuro-regenerative protocols.

• Clinic specialisation: Vega Clinic in Bangkok focuses on regenerative medicine and serves numerous Australian patients.
• Expert credentials: Dr Pongwat Polpong at EDNA Wellness has performed 2,000+ neurosurgical procedures.
• Cell delivery: Experts use intravenous (IV) or intrathecal (IT) injections into the spinal fluid.
• Clinical protocols: Doctors like Dr Chollawat Thongthaisin hold American Board of Regenerative Medicine certification.
• Patient volume: ID Clinic Bangkok serves 4,000 patients annually across its medical and regenerative departments.

Bookimed Expert Insight: Data shows a major difference in how clinics structure recovery stays. ID Clinic Bangkok offers all-inclusive packages with hotel nights. Vega Clinic provides longer 6-day hospital room stays for more intensive monitoring. This hospital-based recovery is vital for patients receiving intrathecal injections. These injections require closer medical supervision than standard IV infusions.

Patient Consensus: Patients travelling to Thailand value the convenience of bundled services. These include airport transfers and clinical coordination. Many choose these facilities because the specialist teams include both neurosurgeons and regenerative medicine experts.